Phase I Clinical Trial Shows Drug Shrinks Melanoma Brain Metastases
• http://www.sciencedaily.comAn experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report in the May 18 issue of The Lancet.